3.2(top 10%)
impact factor
133(top 50%)
papers
1.0K(top 50%)
citations
16(top 50%)
h-index
3.4(top 10%)
impact factor
172
all documents
1.3K
doc citations
25(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1E3 ubiquitin ligases: styles, structures and functionsMolecular Biomedicine202197
2Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid proteinMolecular Biomedicine202076
3Developing inhaled protein therapeutics for lung diseasesMolecular Biomedicine202045
4Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathwaysMolecular Biomedicine202142
5Post-translational modifications in liquid-liquid phase separation: a comprehensive reviewMolecular Biomedicine202242
6Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapyMolecular Biomedicine202238
7Progress in exosome associated tumor markers and their detection methodsMolecular Biomedicine202035
8An overview of PROTACs: a promising drug discovery paradigmMolecular Biomedicine202235
9Profiling chromatin regulatory landscape: insights into the development of ChIP-seq and ATAC-seqMolecular Biomedicine202034
10Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancerMolecular Biomedicine202131
11Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapyMolecular Biomedicine202229
12Targeting regulatory T cells for immunotherapy in melanomaMolecular Biomedicine202122
13The role of the gut microbiota in health and cardiovascular diseasesMolecular Biomedicine202222
14Structural basis for the multimerization of nonstructural protein nsp9 from SARS-CoV-2Molecular Biomedicine202021
15Vesicle trafficking and vesicle fusion: mechanisms, biological functions, and their implications for potential disease therapyMolecular Biomedicine202221
16Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidencesMolecular Biomedicine202020
17Cancer metabolism and intervention therapyMolecular Biomedicine202120
18Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19Molecular Biomedicine202120
19TGF-beta signal transduction: biology, function and therapy for diseasesMolecular Biomedicine202220
20G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer’s diseaseMolecular Biomedicine202119
21Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?Molecular Biomedicine202119
22Development of therapeutic antibodies for the treatment of diseasesMolecular Biomedicine202219
23Metformin in therapeutic applications in human diseases: its mechanism of action and clinical studyMolecular Biomedicine202219
24α-Linolenic acid induces clearance of Tau seeds via Actin-remodeling in MicrogliaMolecular Biomedicine202117
25Extracellular vesicles (exosomes and ectosomes) play key roles in the pathology of brain diseasesMolecular Biomedicine202117
26Integrin-Src-YAP1 signaling mediates the melanoma acquired resistance to MAPK and PI3K/mTOR dual targeted therapyMolecular Biomedicine202016
27cGAS/STING: novel perspectives of the classic pathwayMolecular Biomedicine202015
28Revisiting cancer hallmarks: insights from the interplay between oxidative stress and non-coding RNAsMolecular Biomedicine202014
29Real-time sensing of neurotransmitters by functionalized nanopores embedded in a single live cellMolecular Biomedicine202114
30Drug resistance: from bacteria to cancerMolecular Biomedicine202114
31miR-221/222 sponge abrogates tamoxifen resistance in ER-positive breast cancer cells through restoring the expression of ERαMolecular Biomedicine202113
32Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDSMolecular Biomedicine202013
33Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatmentMolecular Biomedicine202213
34Announcing Molecular BiomedicineMolecular Biomedicine202012
35Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodiesMolecular Biomedicine202212
36The molecular mechanism of acute liver injury and inflammatory response induced by Concanavalin AMolecular Biomedicine202111
37Alterations of the fecal microbiota in relation to acute COVID-19 infection and recoveryMolecular Biomedicine202211
38The role of Hedgehog and Notch signaling pathway in cancerMolecular Biomedicine202211
39Development of therapeutic vaccines for the treatment of diseasesMolecular Biomedicine202211
40Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKAMolecular Biomedicine202110
41Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapiesMolecular Biomedicine202110
42RNA modification: mechanisms and therapeutic targetsMolecular Biomedicine20239
43COVID-19: insights into virus–receptor interactionsMolecular Biomedicine20218
44GMPPB-congenital disorders of glycosylation associate with decreased enzymatic activity of GMPPBMolecular Biomedicine20218
45RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancersMolecular Biomedicine20208
46Structure–activity features of purines and their receptors: implications in cell physiopathologyMolecular Biomedicine20228
47Cleavage of the selective autophagy receptor SQSTM1/p62 by the SARS-CoV-2 main protease NSP5 prevents the autophagic degradation of viral membrane proteinsMolecular Biomedicine20228
48Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancerMolecular Biomedicine20228
49Mibefradil alters intracellular calcium concentration by activation of phospholipase C and IP3 receptor functionMolecular Biomedicine20217
50Stem cell therapy for COVID-19 pneumoniaMolecular Biomedicine20227